BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8634658)

  • 21. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
    Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
    J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.
    Muscat JE; Pittman B; Kleinman W; Lazarus P; Stellman SD; Richie JP
    Biochem Pharmacol; 2008 Oct; 76(7):929-37. PubMed ID: 18703023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.
    Bell DA; Taylor JA; Paulson DF; Robertson CN; Mohler JL; Lucier GW
    J Natl Cancer Inst; 1993 Jul; 85(14):1159-64. PubMed ID: 8320745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population.
    Topinka J; Binková B; Mracková G; Stávková Z; Peterka V; Benes I; Dejmek J; Lenícek J; Pilcík T; Srám RJ
    Environ Mol Mutagen; 1997; 30(2):184-95. PubMed ID: 9329643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S-transferase T1-null and M1-null genotypes.
    Fennell TR; MacNeela JP; Morris RW; Watson M; Thompson CL; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):705-12. PubMed ID: 10919741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
    Moore LE; Baris DR; Figueroa JD; Garcia-Closas M; Karagas MR; Schwenn MR; Johnson AT; Lubin JH; Hein DW; Dagnall CL; Colt JS; Kida M; Jones MA; Schned AR; Cherala SS; Chanock SJ; Cantor KP; Silverman DT; Rothman N
    Carcinogenesis; 2011 Feb; 32(2):182-9. PubMed ID: 21037224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
    van der Hel OL; Peeters PH; Hein DW; Doll MA; Grobbee DE; Kromhout D; Bueno de Mesquita HB
    Pharmacogenetics; 2003 Jul; 13(7):399-407. PubMed ID: 12835615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California.
    Carpenter CL; Yu MC; London SJ
    Nutr Cancer; 2009; 61(4):492-9. PubMed ID: 19838921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
    Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
    J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility.
    Lin HJ; Han CY; Bernstein DA; Hsiao W; Lin BK; Hardy S
    Carcinogenesis; 1994 May; 15(5):1077-81. PubMed ID: 8200072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
    Dallinga JW; Pachen DM; Wijnhoven SW; Breedijk A; van 't Veer L; Wigbout G; van Zandwijk N; Maas LM; van Agen E; Kleinjans JC; van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):571-7. PubMed ID: 9681524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies.
    Zhang R; Xu G; Chen W; Zhang W
    Mol Biol Rep; 2011 Apr; 38(4):2491-7. PubMed ID: 21082260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia.
    Chen CL; Liu Q; Pui CH; Rivera GK; Sandlund JT; Ribeiro R; Evans WE; Relling MV
    Blood; 1997 Mar; 89(5):1701-7. PubMed ID: 9057653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
    Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.
    Engel LS; Taioli E; Pfeiffer R; Garcia-Closas M; Marcus PM; Lan Q; Boffetta P; Vineis P; Autrup H; Bell DA; Branch RA; Brockmöller J; Daly AK; Heckbert SR; Kalina I; Kang D; Katoh T; Lafuente A; Lin HJ; Romkes M; Taylor JA; Rothman N
    Am J Epidemiol; 2002 Jul; 156(2):95-109. PubMed ID: 12117698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.